Downregulation of the cough reflex by aclidinium and tiotropium in awake and anesthetized rabbits
详细信息 查看全文
- 作者：Donatella Mutolo ; donatella.mutolo@unifi.it" class="auth_mail" title="E-mail the corresponding author ; Elenia Cinelli ; Ludovica Iovino ; Tito Pantaleo ; Fulvia Bongianni
- 关键词：Tiotropium ; Aclidinium ; The cough reflex ; Long-acting muscarinic receptor antagonists ; ASICs ; Airway mechanoreceptors
- 刊名：Pulmonary Pharmacology & Therapeutics
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：38
- 期：Complete
- 页码：1-9
- 全文大小：1091 K
文摘
Long-acting muscarinic receptor antagonists (LAMAs) have been reported to attenuate cough in preclinical and clinical studies. The present study was performed on rabbits to compare aclidinium and tiotropium efficacy in the downregulation of the cough reflex. This reflex was evoked by citric acid inhalation in unanesthetized animals and by both citric acid inhalation and mechanical stimulation of the tracheobronchial tree in anesthetized animals 90 min following the inhalation of each drug (nebulizer output always at 1 mL/min). Aclidinium 4 mg/mL and tiotropium 200 μg/mL inhaled in 1 min proved to have similar protective effect on methacholine-induced bronchoconstriction in anesthetized animals. The total dosage employed for aclidinium and tiotropium was 4 mg and 200 μg, respectively. In awake animals, similar reductions in the cough number were observed following 10-min inhalation of each drug with a slight, not significant tendency to higher antitussive effects for aclidinium. In anesthetized animals, 1-min inhalation of each drug caused similar depressant effects on cough responses induced by both mechanical and chemical stimulation. A complete suppression of cough responses to mechanical stimuli was seen in some preparations. The results strongly suggest that the LAMA-induced downregulation of cough may be mediated not only by transient receptor potential vanilloid type 1 channels, as already reported, but also by acid-sensing ion channels and mechanoreceptors. The route of administration along with the more rapid hydrolysis of aclidinium into inactive metabolites minimize potential systemic side effects and give to this drug a very favorable safety profile.